Marval Biosciences Inc — Form D
Marval Biosciences Inc of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-11-02. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-11-02
- Form: D
- Accession: 0001412586-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.5M
- Amount sold: $1.5M
- Investors: 11
- Date of first sale: 2011-10-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-168159
Issuer
- Name: Marval Biosciences Inc
- CIK: 0001412586
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 1441 9TH, SAN DIEGO, CA, 92101-8947
- Phone: 281-802-4776
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Frank Foster | Director | Santa Barbara, CA |
| Russell Lebovitz | Director | San Diego, CA |
| Dan Watkins | Director | Houston, TX |
| Russell Lebovitz | Executive Officer | San Diego, CA |
| Ananth Annapragada | Director | Manvel, TX |
| Ananth Annapragada | Executive Officer | Manvel, TX |
Other filings by this issuer (2)
More